CD8A and cutaneous mastocytosis: A more recent analysis found that among lncRNAs whose expression was correlated with immunology in CM, 56% were significantly associated with CD8+ T‐cell infiltration in CM [152], which has been demonstrated to be a useful biomarker to predict prognosis and response to therapy in CM patients [153].